Stockreport

Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD

AEVI GENOMIC MEDICINE INC  (GNMX) 
Last aevi genomic medicine inc earnings: 11/14 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: aevigenomics.com
PDF PHILADELPHIA, Aug. 14, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has completed enrollment in Part A (n=64) of [Read more]